Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Leukemia Research
|
November 27, 2012
Can we change the disease biology of multiple myeloma?
Ivan Borrello
British Journal of Haematology
|
January 6, 2009
Lenalidomide in renal insufficiency--balancing the risks and benefits
Ivan Borrello
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
August 26, 2011
The immune microenvironment of myeloma
Kimberly Noonan, Ivan Borrello
Blood
|
August 11, 2016
The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
Valentina Hoyos, Ivan Borrello
Cytokine & Growth Factor Reviews
|
March 20, 2002
GM-CSF-based cellular vaccines: a review of the clinical experience
Ivan Borrello, Drew Pardoll
The Journal of Clinical Investigation
|
April 30, 2019
BCMA CAR T cells: the winding path to success
Ivan Borrello, Philip H Imus
Cancer Treatment and Research
|
October 4, 2016
Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma
Susan J Lee, Ivan Borrello
Frontiers in Immunology
|
April 12, 2016
Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy
Ivan Borrello, Kimberly A Noonan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2012
Autologous stem cell transplantation and multiple myeloma cancer stem cells
William Matsui, Ivan Borrello, Constantine Mitsiades
Seminars in Cancer Biology
|
September 20, 2005
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression
Paolo Serafini, Ivan Borrello, Vincenzo Bronte
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Leukemia Research
|
November 27, 2012
Can we change the disease biology of multiple myeloma?
Ivan Borrello
British Journal of Haematology
|
January 6, 2009
Lenalidomide in renal insufficiency--balancing the risks and benefits
Ivan Borrello
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
August 26, 2011
The immune microenvironment of myeloma
Kimberly Noonan, Ivan Borrello
Blood
|
August 11, 2016
The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
Valentina Hoyos, Ivan Borrello
Cytokine & Growth Factor Reviews
|
March 20, 2002
GM-CSF-based cellular vaccines: a review of the clinical experience
Ivan Borrello, Drew Pardoll
The Journal of Clinical Investigation
|
April 30, 2019
BCMA CAR T cells: the winding path to success
Ivan Borrello, Philip H Imus
Cancer Treatment and Research
|
October 4, 2016
Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma
Susan J Lee, Ivan Borrello
Frontiers in Immunology
|
April 12, 2016
Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy
Ivan Borrello, Kimberly A Noonan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2012
Autologous stem cell transplantation and multiple myeloma cancer stem cells
William Matsui, Ivan Borrello, Constantine Mitsiades
Seminars in Cancer Biology
|
September 20, 2005
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression
Paolo Serafini, Ivan Borrello, Vincenzo Bronte
Page
of 9